Fady I. Sharara, M.D., FACOG

Board Certified

Fady I. Sharara, M.D, FACOG, is a Board Certified Reproductive Endocrinologist / Infertility specialist (since 1996), and a Board Certified Obsterician / Gynecologist (since 1994).

Education

Dr. Sharara received his B.S in Chemistry in 1982, and his M.D in 1986 from the American University of Beirut. He was on the Dean's honor list during his premedical and medical studies. He then completed his residency in OB/GYN at George Washington University Hospital in Washington, DC in 1991, followed by a fellowship in Reproductive Endocrinology and Infertility from 1991 to 1994 at the National Institutes of Health in Bethesda, MD (which had only one spot per year at the time).

Fertility Center & University Professor

He then moved to Chicago in July 1994 where he was an Assistant Professor at the University of Illinois and Michael Reese Fertility Center between 1994 and 1996. He then returned East to the University of Maryland in July 1996 where he was Assistant Professor and head of the IVF program from 1996 to  May 2000. He was promoted to Associate Professor before his departure from the University of Maryland. He became an Associate Clinical Professor at George Washington University from 2003-2009. Dr Sharara is currently Clinical Professor in the Department of Obstetrics and Gynecology at the George Washington University in Washington, D.C.

Founder and Medical Director for
the Virginia Center for Reproductive Medicine (VCRM)

Dr Sharara then became the founder and Medical Director for the Virginia Center for Reproductive Medicine (VCRM), with offices in Reston, VA.

Dr Sharara has published more than 80 scientific papers and book chapters dealing with Infertility and Assisted Reproductive Technologies, and is a sought after speaker in his area of expertise, namely IVF and assisted reproduction. He is on the Speakers Bureau for multiple companies.

He is the recipient of numerous prestigious awards, and is on the speaker's bureau for multiple companies. Dr Sharara is also a reviewer for Fertility and Sterility and Human Reproduction, the two leading scientific journals in the area of Reproduction, along with Journal of Assisted Reproduction and Genetics, Human Fertility, American Journal of Obstetrics and Gynecology, Journal of Obsterics and Gynecology Research, Imaging in Medicine, and the Middle East Fertility Society Journal. Dr Sharara has been named one of America's Who's Who in Medicine and Health Care every year from 2002 to 2009, Who's Who in America in 2004-09, America's Top Obstetricians and Gynecologists in 2007, 2008, and 2009.

Dr Sharara was also received the 2004 International Scientist of the Year award, 2004 International Health Professional of the Year award, and has been named as one of the Washington area top doctors in Infertility by the Washingtonian magazine in 2005-2008.

Dr Sharara has been a member of the Society of Assisted Reproductive Technology (SART) Practice Committe since 2007. The Practice Committe has only 6 members, and is responsible for drafting new guidelines and articles pertaining to the latest Assisted Reproductive Technologies and then submitting them for approval by the American Society of Reproductive Medicine (ASRM) Practice Committee.

Despite his significant clinical and administrative load, Dr Sharara is still committed to conducting clinical research, and he gives over 30 lectures per year both nationally and internationally. At VCRM, there are few ongoing  clinical trials to improve ART success, once compared to twice gonadotropin dosing, and for prevention of ovarian hyperstimulation syndrome (OHSS).

Dr Sharara selected bibliography:

1: Incidence of monozygotic twins in blastocyst and cleavage stage assisted reproductive technology cycles.

Sharara FI, Abdo G.

Fertil Steril. 2009 Feb 11. [Epub ahead of print]

2: Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves outcome in IVF.

Sharara FI.

Hum Reprod. 2009 Mar;24(3):756; author reply 756-7. Epub 2008 Dec 19.

3: The role of fallopian tube anastomosis in training fellows: a survey of current reproductive endocrinology fellows and practitioners.

Armstrong A, Neithardt AB, Alvero R, Sharara FI, Bush M, Segars J.

Fertil Steril. 2004 Aug;82(2):495-7.

4: Successful pregnancies in the setting of exaggerated endometrial thickness.

Quintero RB, Sharara FI, Milki AA.

Fertil Steril. 2004 Jul;82(1):215-7.

5: Assessment of ovarian reserve. Is there still a role for ovarian biopsy? First do no harm!

Sharara FI, Scott RT.

Hum Reprod. 2004 Mar;19(3):470-1. Epub 2004 Jan 29.

6: Value of mid-luteal oestradiol level: prognostic implications for IVF.

Sharara FI.

Hum Reprod. 2001 Nov;16(11):2476.

7: Increased body mass index has a deleterious effect on in vitro fertilization outcome.

Loveland JB, McClamrock HD, Malinow AM, Sharara FI.

J Assist Reprod Genet. 2001 Jul;18(7):382-6.

8: Ovarian volume and antral follicle counts as indicators of menopausal status.

Flaws JA, Langenberg P, Babus JK, Hirshfield AN, Sharara FI.

Menopause. 2001 May-Jun;8(3):175-80.

9: Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF.

Sharara FI, McClamrock HD.

Hum Reprod. 2001 Mar;16(3):500-3.

10: Evaluation of basal estradiol levels in assisted reproductive technology cycles.

Frattarelli JL, Bergh PA, Drews MR, Sharara FI, Scott RT.

Fertil Steril. 2000 Sep;74(3):518-24.

11: Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program.

Sharara FI, McClamrock HD.

Fertil Steril. 2000 Jun;73(6):1170-3.

12: Reply of the authors:

Sharara FI.

Fertil Steril. 2000 May;73(5):1071-2.

13: Secondary amenorrhea and infertility caused by an inhibin-B-producing ovarian fibrothecoma.

Meyer AC, Papadimitriou JC, Silverberg SG, Sharara FI.

Fertil Steril. 2000 Feb;73(2):258-60.

14: Ovarian volume and menopausal status.

Flaws JA, Rhodes JC, Langenberg P, Hirshfield AN, Kjerulff K, Sharara FI.

Menopause. 2000 Jan-Feb;7(1):53-61.

15: Environmental factors in infertility.

Hruska KS, Furth PA, Seifer DB, Sharara FI, Flaws JA.

Clin Obstet Gynecol. 2000 Dec;43(4):821-9.

16: Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration.

Sharara FI, Lim J, McClamrock HD.

J Assist Reprod Genet. 1999 Nov;16(10):523-8.

17: Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.

Sharara FI, McClamrock HD.

Hum Reprod. 1999 Nov;14(11):2777-82.

18: The role of hydrosalpinx in IVF: are we getting closer to an answer?

Sharara FI.

Fertil Steril. 1999 Sep;72(3):567-8. No abstract available.

19: High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.

Sharara FI, McClamrock HD.

Fertil Steril. 1999 Sep;72(3):401-5.

20: Elevated serum Chlamydia trachomatis IgG antibodies. Association with decreased implantation rates in GIFT.

Sharara FI, Queenan JT Jr.

J Reprod Med. 1999 Jul;44(7):581-6.

21: The effect of aging on ovarian volume measurements in infertile women.

Sharara FI, McClamrock HD.

Obstet Gynecol. 1999 Jul;94(1):57-60.

22: The effect of pituitary desensitization on ovarian volume measurements prior to in-vitro fertilization.

Sharara FI, Lim J, McClamrock HD.

Hum Reprod. 1999 Jan;14(1):183-5.

23: The role of hydrosalpinx in IVF: simply mechanical?

Sharara FI.

Hum Reprod. 1999 Mar;14(3):577-8. Review. No abstract available.

24: Endometrial fluid collection in women with PCOS undergoing ovarian stimulation for IVF. A report of four cases.

Sharara FI, Prough SG.

J Reprod Med. 1999 Mar;44(3):299-302.

25: Low and high responders--at what levels of serum estradiol do things start to get fuzzy?

Sharara FI.

Fertil Steril. 1999 Mar;71(3):583-6.

26: "Poor responders" to gonadotropins and levels of antibodies to Chlamydia trachomatis?

Sharara FI.

Fertil Steril. 1999 Feb;71(2):388-9.

27: Complete uterine septum with cervical duplication, longitudinal vaginal septum and duplication of a renal collecting system. A case report.

Sharara FI.

J Reprod Med. 1998 Dec;43(12):1055-9.

28: Environmental toxicants and female reproduction.

Sharara FI, Seifer DB, Flaws JA.

Fertil Steril. 1998 Oct;70(4):613-22.

29: The detection of diminished ovarian reserve in infertile women.

Sharara FI, Scott RT Jr, Seifer DB.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):804-12.

30: Effects of hydrosalpinx on IVF outcome: the search goes on.

Sharara FI.

Hum Reprod. 1997 Dec;12(12):2853-4.

31: Endometrial fluid collection in women with hydrosalpinx after human chorionic gonadotrophin administration: a report of two cases and implications for management.

Sharara FI, McClamrock HD.

Hum Reprod. 1997 Dec;12(12):2816-9.

32: Elevated serum Chlamydia trachomatis IgG antibodies. What do they mean for IVF pregnancy rates and loss?

Sharara FI, Queenan JT Jr, Springer RS, Marut EL, Scoccia B, Scommegna A.

J Reprod Med. 1997 May;42(5):281-6.

33: Role of growth hormone in ovarian physiology and onset of puberty.

Sharara FI, Giudice LC.

J Soc Gynecol Investig. 1997 Jan-Feb;4(1):2-7.

34: Value of growth hormone in ovulation induction?

Sharara FI.

Fertil Steril. 1996 Jun;65(6):1259-61.

35: In-vitro fertilization outcome in women with hydrosalpinx.

Sharara FI, Scott RT Jr, Marut EL, Queenan JT Jr.

Hum Reprod. 1996 Mar;11(3):526-30.

36: Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.

Sharara FI, Nieman LK.

Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):814-9.

37: Measures of association--smoking and fecundity.

Sharara FI.

Fertil Steril. 1995 Jun;63(6):1350-2. No abstract available.

38: Evaluation of the Tru-Trax cervical mucus penetration test in predicting fertilization and pregnancy rates in in-vitro fertilization.

Sharara FI, Illions EH, Coddington CC 3rd, Scott RT Jr.

Hum Reprod. 1995 Jun;10(6):1481-5.

39: Characterization of Tru-Trax in-vitro penetration testing of cervical mucus.

Sharara FI, Beatse SN, Bailey SA, Neal GS, Coddington CC 3rd, Scott RT Jr.

Hum Reprod. 1994 Nov;9(11):2027-31.

40: Growth hormone receptor gene expression in the mouse uterus: modulation by gonadal steroids.

Sharara FI, Bhartiya D, Nieman LK.

J Soc Gynecol Investig. 1994 Oct-Dec;1(4):285-9.

41: Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test.

Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT Jr.

Fertil Steril. 1994 Aug;62(2):257-62.

42: Identification and cellular localization of growth hormone receptor gene expression in the human ovary.

Sharara FI, Nieman LK.

J Clin Endocrinol Metab. 1994 Aug;79(2):670-2.

43: Prenatal diagnosis of a giant cavernous hemangioma in association with nonimmune hydrops. A case report.

Sharara FI, Khoury AN.

J Reprod Med. 1994 Jul;39(7):547-9.

44: Watchful waiting and craniopharyngioma.

Sharara FI, Chrousos GP, Patronas NJ.

Ann Intern Med. 1992 Nov 15;117(10):876-7.